NAGE Stock-Based Compensation
Niagen Bioscience Inc · Stock-Based Compensation
NAGE Stock-Based Compensation
Latest reported$6.94Mperiod ending
NAGE Stock-Based Comp ($0.00 → $6.94M)
Annual stock-based compensation
High-resolution chart · PNG
NAGE stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 6,067,000 | |
| 3,656,000 | |
| 4,751,000 | |
| 5,739,000 | |
| 6,195,000 | |
| 6,936,000 | |
| 7,172,000 | |
| 6,371,000 | |
| 4,605,000 | |
| 1,193,782 | |
| 1,977,611 | |
| 2,916,924 | |
| 1,287,917 | |
| 2,703,253 | |
| 2,969,150 | |
| 1,262,071 | |
| 205,858 | |
| 121,185 | |
| 0 |